<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Electronic and Electrical Engineering</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7067796F-8A93-4C9A-A034-5FC55BC8720D"><gtr:id>7067796F-8A93-4C9A-A034-5FC55BC8720D</gtr:id><gtr:name>icoMetrix</gtr:name><gtr:address><gtr:line1>Tervuusesteeenweg 244</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F113D73A-143F-41B6-9680-98AF837D51DF"><gtr:id>F113D73A-143F-41B6-9680-98AF837D51DF</gtr:id><gtr:name>University of Antwerp</gtr:name><gtr:address><gtr:line1>Universiteitsplein 1</gtr:line1><gtr:line4>Antwerp</gtr:line4><gtr:line5>B-2610</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D13E419A-F7DA-4588-ADC9-EEE34E50AC44"><gtr:id>D13E419A-F7DA-4588-ADC9-EEE34E50AC44</gtr:id><gtr:name>Alzheimer's Society</gtr:name><gtr:address><gtr:line1>Devon House</gtr:line1><gtr:line2>58 St Katherine's Way</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>E1W 1JX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E9C787-1A64-4626-9702-3BA402E2D8CB"><gtr:id>C1E9C787-1A64-4626-9702-3BA402E2D8CB</gtr:id><gtr:name>Siemens Public Limited Company</gtr:name><gtr:address><gtr:line1>Sir Williams Siemens House</gtr:line1><gtr:line2>Princess Road</gtr:line2><gtr:postCode>M20 2UR</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F327D9BD-7240-42B0-85D7-28BE87B9576C"><gtr:id>F327D9BD-7240-42B0-85D7-28BE87B9576C</gtr:id><gtr:name>Novartis Pharma AG</gtr:name><gtr:address><gtr:line1>WKL - 136.5.22</gtr:line1><gtr:line4>Basel</gtr:line4><gtr:line5>CH 4002</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/093518AF-1083-4B66-9442-8ED77D481FE6"><gtr:id>093518AF-1083-4B66-9442-8ED77D481FE6</gtr:id><gtr:name>Philips Medical Systems</gtr:name><gtr:address><gtr:line1>Rontgenstrasse 24</gtr:line1><gtr:line4>Hamburg</gtr:line4><gtr:postCode>D-22335</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/746AD253-C2D4-40F6-89B0-C7E1E7424D2B"><gtr:id>746AD253-C2D4-40F6-89B0-C7E1E7424D2B</gtr:id><gtr:name>IXICO Ltd</gtr:name><gtr:address><gtr:line1>15 Long Lane</gtr:line1><gtr:postCode>EC1A 9PN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D0E5B878-1B35-40AE-8EFF-63119BBFB1AC"><gtr:id>D0E5B878-1B35-40AE-8EFF-63119BBFB1AC</gtr:id><gtr:name>CEA - Atomic Energy Commission</gtr:name><gtr:address><gtr:line1>CEA Saclay</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1EDCEB1C-C324-4860-9BAE-397B982E2464"><gtr:id>1EDCEB1C-C324-4860-9BAE-397B982E2464</gtr:id><gtr:name>Hamamatsu Photonics UK Ltd</gtr:name><gtr:address><gtr:line1>Hamamatsu Photonics UK Ltd</gtr:line1><gtr:line2>2 Gladbeck Way</gtr:line2><gtr:line3>Windmill Hill</gtr:line3><gtr:line4>Enfield</gtr:line4><gtr:postCode>EN2 7JA</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19DDB526-A935-4DE2-9C06-A7856EDD7DB9"><gtr:id>19DDB526-A935-4DE2-9C06-A7856EDD7DB9</gtr:id><gtr:name>ESI Group</gtr:name><gtr:address><gtr:line1>36800 Woodward Avenue</gtr:line1><gtr:line2>Suite 200</gtr:line2><gtr:line4>Bloomfield Hills</gtr:line4><gtr:line5>MI 48304</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D2AB573-314E-4AAF-9604-5CF494A61C8D"><gtr:id>1D2AB573-314E-4AAF-9604-5CF494A61C8D</gtr:id><gtr:name>Micro Dimensions</gtr:name><gtr:address><gtr:line1>Rupert Mayer-Stra?e 44//64.07</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FF4970EE-DB0A-48FA-9C87-BB6C90D7D47B"><gtr:id>FF4970EE-DB0A-48FA-9C87-BB6C90D7D47B</gtr:id><gtr:firstName>Aneurin</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Kennerley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AECB89A1-215A-45FF-9BC9-FD65453C24E6"><gtr:id>AECB89A1-215A-45FF-9BC9-FD65453C24E6</gtr:id><gtr:firstName>Alejandro</gtr:firstName><gtr:otherNames>Federico</gtr:otherNames><gtr:surname>Frangi</gtr:surname><gtr:orcidId>0000-0002-2675-528X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2B0BE437-69D2-4AC6-8B47-D872133060EA"><gtr:id>2B0BE437-69D2-4AC6-8B47-D872133060EA</gtr:id><gtr:firstName>Derek</gtr:firstName><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C77B8EA7-D327-41B4-BCE5-5878856CF7F2"><gtr:id>C77B8EA7-D327-41B4-BCE5-5878856CF7F2</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Robin</gtr:otherNames><gtr:surname>Highley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D96679F-7B87-4095-8643-EDEC89A16D03"><gtr:id>6D96679F-7B87-4095-8643-EDEC89A16D03</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Geoffrey</gtr:otherNames><gtr:surname>Ince</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0BDD3DA2-42AD-4773-B6FB-C16D7D53A22D"><gtr:id>0BDD3DA2-42AD-4773-B6FB-C16D7D53A22D</gtr:id><gtr:firstName>Geoff</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Parker</gtr:surname><gtr:orcidId>0000-0003-2934-2234</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/28D5D731-EA88-401C-B56D-19EEB0847FA8"><gtr:id>28D5D731-EA88-401C-B56D-19EEB0847FA8</gtr:id><gtr:firstName>Leandro</gtr:firstName><gtr:surname>Beltrachini</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7CF84949-C68B-4246-B2D6-78DEBB33ECD5"><gtr:id>7CF84949-C68B-4246-B2D6-78DEBB33ECD5</gtr:id><gtr:firstName>Annalena</gtr:firstName><gtr:surname>Venneri</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3D985FC3-CBA5-4BE3-9CCD-32417DE17A02"><gtr:id>3D985FC3-CBA5-4BE3-9CCD-32417DE17A02</gtr:id><gtr:firstName>Zeike</gtr:firstName><gtr:otherNames>Amos</gtr:otherNames><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B60B1B00-8FB3-473C-8F4C-950E122387F5"><gtr:id>B60B1B00-8FB3-473C-8F4C-950E122387F5</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Wilkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FM006328%2F1"><gtr:id>BABC0030-1281-45DC-8558-44FE51168751</gtr:id><gtr:title>OCEAN: One-stop-shop microstructure-sensitive perfusion/diffusion MRI: Application to vascular cognitive impairment</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/M006328/1</gtr:grantReference><gtr:abstractText>The term &amp;quot;dementia&amp;quot; is used to describe a syndrome that results, initially, in cognitive function impairment and in many cases, a descending staircase of psychological dysfunction, leading eventually to death. 
It is a major socio-economic challenge with care costs approaching 1% of global GDP. Several conditions that lead to serious loss of cognitive ability are grouped under this syndrome, including Alzheimer's disease (AD), Vascular Dementia (VaD), Frontotemporal Dementia, etc. A high publicity announcement was made in 2012, by the Prime Minister, emphasising the high priority that should be given to dementia-related research and that funding will more than double in the immediate future, to partially remedy the fact that the overwhelming impact of the syndrome has been over-looked (Guardian, 26/3/12). On Dec 2013, the G8 Summit hosted in London brought together G8 ministers, researchers, pharmaceutical companies, and charities to develop co-ordinated global action on dementia. 

Dementia has marked adverse effects on the quality of life of tens of millions of people (both patients and carers) and exerts tremendous pressure on healthcare systems, especially when clear trends towards an ageing population, changing environmental influences and contemporary lifestyle choices are considered. Ca. 35M people suffer from dementia worldwide, a figure to quadruple by 2050. Europe and North America share a disproportionally high burden: the effects of ageing are particularly stark for these regions, exacerbating the healthcare provision implications. 

The Clinical Relevance: Vascular Cognitive Impairment (VCI). VCI defines alterations in cognition attributable to cerebrovascular causes, ranging from subtle or fixed deficits to full-blown dementia. VCI is a wide and accepted term referring to the &amp;quot;syndrome with evidence of clinical stroke or subclinical vascular brain injury and cognitive impairment affecting at least one cognitive domain&amp;quot;, with resulting VaD being its most severe form. VaD is responsible for at least 20% of dementias, second only to AD, with a prevalence doubling every 5. 3 years. Several trials examined cholinesterase inhibitors for the treatment of vascular dementia, but the benefits are very modest, except in the individuals with a combination of AD and VaD. Vascular changes result in white matter (WM) damage (leukoaraiosis), which profoundly affect the fidelity of the information transfer underlying brain function and cognitive health8. 

Cerebral Magnetic Resonance Imaging (MRI) of Diffusion and Perfusion. MRI is a medical imaging technique affording non-invasive investigation of anatomy and tissue function, which is particularly suited to studying cognitive disorders due to its sensitivity and reliability. Our main interest is to characterise vascular and non-vascular tissues using quantitative diffusion and perfusion MR. Our overall aim is to characterise and quantify early differential alterations in brain blood transport and subsequent microstructural tissue damage using one-stop-shop perfusion/diffusion MR GSI incorporating novel MR signal models and optimal MR sequence design based on new human brain histomorphometric data in health and disease.</gtr:abstractText><gtr:potentialImpactText>Dementia already is one of society's biggest medical challenges. No cures are so far available. Yet, research is intense and strong candidate therapies are on the horizon. Given the variety of causes and aetiologies of dementia, reliable identification of the underlying pathologies is a requisite for therapy effectiveness. Differential diagnosis is therefore key. Effectiveness, also, is greatly modulated by the level of disease progression in individuals. Even where outright cure is unrealistic, evidence already suggests that lifestyle changes and other treatments can delay the progression of symptoms, provided these are identified sufficiently early. This is of enormous significance to sufferers and their families. Societal economic implications aside, the quality of life benefits for sufferers from prolonged independence, and the emotional and financial alleviation for families and carers are substantial. Early diagnosis is therefore key. It is in the provision of differential and early diagnosis that the technologies developed within OCEAN can have a serious impact. 

Knowledge management and exchange with other key EU-, RCUK- and NIHR-funded initiatives. To maximise synergies with other relevant initiatives and ensure knowledge cross-fertilisation, we set up a Scientific Advisory Board (SAB) experienced in relevant engineering and physical sciences and with a track record of clinical translation of research results. This cadre of academics includes world class scientists in the areas of MR diffusion imaging, medical image computing, and computational modelling. 

Industrial engagement and commercial take-up. Several companies are committed to OCEAN thus incorporating a technological and exploitation dimension from the outset of the project. Companies were selected to cover all key areas and technologies in OCEAN where exploitable outcomes or collaborations are anticipated; previous or ongoing research collaborations were also accounted. Statements of support are appended.
Microscopy data will be made available to community. OCEAN is committed to making the multimodal image database of light and electron microscopy and 7T MRI brain tissue data available online by the end of the project. We shall also make available the quantitative statistics of microstructural composition and properties. Access to this unique resource will be made online via a project portal built and
managed jointly by SITraN and CISTIB-INSIGNEO.

MR GSI Image Analysis &amp;amp; Visualisation Tool. Once validation of the modelling methodologies has taken place, these tools will be made available to the wider clinical and research community. We plan to prototype an MR GSI Image Analysis &amp;amp; Visualisation Tool based on GIMIAS (www.gimias.org), an open-source platform developed at CISTIB. 

From proof of principle and feasibility to demonstration of clinical impact. Once we have established the feasibility of MR GSI and evaluated it in simulation, phantom studies and short series of volunteers, we will seek follow-up funding streams to conduct a clinical proof-of-concept in a large cohort. This will be designed to assess the effectiveness of MR GSI for early detection of VCI-related disorders and, importantly, the differentiation of pathological mechanisms that is essential for therapy formulation.

Engaging patient and public in research through the Dementia Public and Patient Involvement (PPI) group. We have partnered with the Alzheimer's Society, which will contribute two volunteers in our Scientific and Clinical Advisory Boards, respectively. Funds have been set apart according to the INVOLVE guidance to facilitate the participation of these volunteers.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2015-03-31</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1302401</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Project meeting September 2015 (Virtual)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D69E9424-9213-4785-893B-CC290398538B</gtr:id><gtr:impact>Project meeting attended for different project institutions to discuss project progress

14:00 Welcome 
14:05 Review outstanding action from last meeting 
14:10 Miscellaneous updates:
1. Recruitment: Sheffield (CISTIB, SITRAN), Manchester.
2. Institutional agreement
3. Members area in website
4. Summary of the visit to Manchester
14:30 Progress to date:
1. Microscopy scanner in place 
2. IT issues regarding the scanner / Online access to data
3. Test samples from CFAS
4. Imaging update
14:50 Future events:
1. Next Skype meeting
2. Meeting in Sheffield regarding phantom construction (Sept. 2015)
3. Diffusion UK meeting (Nov. 2015) + stakeholders
4. Meeting in Cardiff (Feb. 2016)
15:10 AOB</gtr:impact><gtr:outcomeId>56de4bba108c08.23266402</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Development o the physical phantom (Project Meeting)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7127FC6A-AC6A-45E1-B5AA-BCF737BE8ADB</gtr:id><gtr:impact>Nine members of the project from Sheffield and Manchester met to discuss project progress as well to agree on the plan for the development of the physical phantom and explore other opportunities for collaboration</gtr:impact><gtr:outcomeId>56dd8ee27e7776.64983037</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.qbi-lab.org/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with Dr Jan Sijbers' group (Virtual)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BDB2EE29-8713-4238-83A9-FEA4CF3CECBA</gtr:id><gtr:impact>Virtual meeting with Dr Jan Sijbers' group (Vision Lab, University of Antwerp, Antwerpen, Belgium) for finding new collaborations between the research groups (fifteen attendees).</gtr:impact><gtr:outcomeId>56df779fd3bed8.39382806</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://visielab.uantwerpen.be/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kick-Off Meeting. University of Sheffield</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>45505C42-4BB9-4A9B-ABD6-1D6E5585421A</gtr:id><gtr:impact>Formal Kick-off meeting attended by all PIs, with the following agenda.

10:00am Welcome, domestics
10:05am Introduction round
10:20am OCEAN: Vision and Overview 
10:35am Vascular dementia and the clinical relevance of OCEAN 
10:50am Pathology and histology in OCEAN
11:05am Overview of CUBRIC and contributions to OCEAN
11:20am Biomimetic phantom development: update and plans
11:30am CISTIB Update on microstructure and numeric model development 
11:45am Discussion and identification of actions to follow on
- Identify critical items requiring further discussion
12:15am General coordination and next steps
- Histology protocol internal draft, draft to Adv Board
- Biomimetic phantom specification: visit to Manchester 
- Visit to CUBRIC: possibilities of experimental set ups
- Other actions emerging from the meeting

- Meeting with stakeholders (Industry, Alz Soc, Adv Board)
- Updated on job advertisements and recruitment
- Institutional Agreements Status

12:30am Conclusions &amp;amp; Meeting Close</gtr:impact><gtr:outcomeId>56dd8d3cd51208.23300707</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.ocean-mri.org/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific Advisory Board 2015. University of Sheffield</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>60CBF0BB-267C-466D-874A-B269FAB7EFD1</gtr:id><gtr:impact>The SAB was attended by seventeen people with the agenda below, particularly relevant at this stage was the feedback gathered for the Neuropathology and Imaging Protocol from PB and SAB members: Prof Daniel Alexander(UCL), Dr Jacques-Donald Torunier(KCL), Prof Jonathan Clayden (TUM), Dr Helen Stolp(KCL), Dr Laura Parkes(UOM)

Agenda:
10.00 Introduction Prof Alejandro Frangi
10.10 OCEAN: Progress so far Leandro Beltrachini
10.20 Neuropathology and Imaging protocol Leandro Beltrachini
10.50 Update from Manchester Geoff Parker
11.10 General update on the project &amp;quot;Quantification of vascular and neuronal pathology in dementia using PET and MRI&amp;quot;
11.30 Discussion &amp;amp; Summary
12.00 Lunch</gtr:impact><gtr:outcomeId>56dd95b30c5402.14235353</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.ocean-mri.org/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting in CUBRIC (Cardiff)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D8F21723-DC98-41E8-A0EA-DE1ED5109189</gtr:id><gtr:impact>Visit to Derek Jones's group and the new national facilities to evaluate technical progress in the project and identify additional collaborations</gtr:impact><gtr:outcomeId>56dd97f018e664.69262712</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://sites.cardiff.ac.uk/cubric/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the GLIA workshop. University of Sheffield.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9ED36AF0-C07F-4D19-A2CF-C4718E778DDB</gtr:id><gtr:impact>Work related to this project (OCEAN) was presented in this workshop aimed to show different angles for studying white matter tissue components. The presentation was entitled &amp;quot;Random generation of white matter models for in silico MRI studies&amp;quot;, which is a crucial component of the main proposal (WP. 1). As a result, we established clear links with clinicians working in the field (from both within and outside the University of Sheffield).</gtr:impact><gtr:outcomeId>56dd892fc656f4.94158553</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:url>http://www.ocean-mri.org/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Project Meeting June 2015 (Virtual)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DEED94D8-0662-4A0E-9CF6-F70237D526C3</gtr:id><gtr:impact>project board teleconference with participation of the different institutions to discuss the following topics
14:00 Histology protocol internal draft, draft to Advisory Board
14:15 Biomimetic phantom specification: visit to Manchester 
14:25 Visit to CUBRIC: possibilities of experimental set ups
14:35 Agree dates for meeting with stakeholders (Industry, Alz Soc, Adv Board)
14:45 Update on recruitment
14:55 Institutional Agreements Status
15:00 Project website and mailing lists
15:05 AOB</gtr:impact><gtr:outcomeId>56de4ae6dbf8c2.23686278</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting in Lisbon at the Champalimaud centre for the unknown</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6D3AFE6A-793B-45DD-BFE6-4C5493A34920</gtr:id><gtr:impact>Visit to Noam Shemesh's group to identify new collaborations with key centres/research groups in Europe. Established preliminary lines of collaboration in the lines of this project. Got extremely valuable comments related to the histology protocol</gtr:impact><gtr:outcomeId>56dd968fa64b20.28580287</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://neuro.fchampalimaud.org/en/research/investigators/research-groups/group/Shemesh/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2015 Diffusion UK meeting. University of Sheffield</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>71C7261F-E09B-404B-B611-3BAB2C09C208</gtr:id><gtr:impact>This meeting drew together researchers from the field of diffusion MRI. This included academics and PhD students from different institutes within the UK and Ireland. The day included poster and talks given by both senior academics and junior researchers working on the characterisation brain microstructure by means of diffusion MRI. The event was held in the Graduate Teaching Building of the Faculty of Engineering at the University of Sheffield (www.sheffield.ac.uk/faculty/engineering). The meeting had a particular focus on the use of dMRI for finding early biomarkers of neurodegenerative diseases. Presenters included Marc Jones (KCL), Fenglei Zhou (Manchester University), Jonathan Clayden (UCL), Jacques-Donald Tournier (KCL), and Andrada Ianus (UCL). The event had approximately 50 participants either presenting posters or attending the event. The day was led by Leandro Beltrachini (CISTIB, The University of Sheffield). The event was a success, the excellent attendance and the quality of the posters and the presentations were engaging and explored the facets of diffusion MRI. The meeting allowed the attendees to exchange of ideas and the fostering of future collaborations.</gtr:impact><gtr:outcomeId>56dd82c426cc48.27824388</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ocean-mri.org/index.php/news/diffusion-uk-meeting</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Learned Societies Fund (University of Sheffield)</gtr:department><gtr:description>Learned Society Fund 16/17 - Funding for conference/workshop attendance</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>University of Sheffield</gtr:fundingOrg><gtr:id>285297C1-E5B2-4B97-B6AD-78D7531CDDA3</gtr:id><gtr:outcomeId>58caaf25bb2ff4.50111647</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Educational Stipend for Students</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>International Society for Magnetic Resonance in Medicine (ISMRM)</gtr:fundingOrg><gtr:id>D4236B2C-11CB-4EDE-BE18-BB9F3F703C73</gtr:id><gtr:outcomeId>58caae079c11e4.26335728</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We developed a computational framework for simulation of diffusion MRI data and for the generation of realistic models of white matter. This will allow to perform sensitivity analysis of diffusion MRI to changes in the white matter due to vascular dementia.

We have developed a more robust method to simultaneously estimate diffusion and perfusion directional properties in brain white matter from MRI.</gtr:description><gtr:exploitationPathways>Development of more accurate methods base in the presented approach.</gtr:exploitationPathways><gtr:id>06CBF96C-00C5-497D-997E-C472A6D46A95</gtr:id><gtr:outcomeId>56ddbe0b55b138.95332141</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.sciencedirect.com/science/article/pii/S1090780715001743</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>OCEAN is committed to making the multimodal image database of light and electron microscopy and 7T MRI brain tissue data available online by the end of the project. We shall also make available the quantitative statistics of microstructural composition and properties. Access to this unique resource will be made online via a project portal built and managed jointly by SITraN and CISTIB.</gtr:description><gtr:id>2BFE9282-06A5-439A-8493-C40CC4752F06</gtr:id><gtr:impact>Initial version of the database with an initial set of data acquired is currently available for internal validation and verification by CISTIB AND SITRaN teams</gtr:impact><gtr:outcomeId>56ddab63610a27.97228922</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Scanned Tissue Database. Univeristy of Sheffield.</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>A new diffusion MRI protocol involving two sequential gradient directions for a single signal detection (double-direction diffusion encoding). Based on that the corresponding MRI signal model has been developed. A estimation algorithm has been developed and implemented for the generalization of the microstructural NODDI model to double-direction diffusion encoding.</gtr:description><gtr:id>5924BAA4-7ED2-4479-A96E-311A491E4A2A</gtr:id><gtr:impact>This new protocol is expected to improve the robustness and accuracy of the quantification of the microstructural characteristics of white matter from MRI, reducing the required acquisition time.</gtr:impact><gtr:outcomeId>58cab3f39161d1.44133714</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Microstructure MRI signal model for double-direction diffusion encoding.</gtr:title><gtr:type>Computer model/algorithm</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>05A7AEE3-DC60-40E5-8A6E-264A832D3816</gtr:id><gtr:title>Subject-specific multi-poroelastic model for exploring the risk factors associated with the early stages of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Interface focus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/125b30f1ee43c43d591c03dec09281c2"><gtr:id>125b30f1ee43c43d591c03dec09281c2</gtr:id><gtr:otherNames>Guo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2042-8898</gtr:issn><gtr:outcomeId>5a352da39fbfd5.52482553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23129893-F2A2-4411-BF55-B68DC9294664</gtr:id><gtr:title>A parametric finite element solution of the generalised Bloch-Torrey equation for arbitrary domains.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085a9847126e7c1714dcf8c4f166ebf1"><gtr:id>085a9847126e7c1714dcf8c4f166ebf1</gtr:id><gtr:otherNames>Beltrachini L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn><gtr:outcomeId>56dd812e94e3e8.84196220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6635ABD1-C049-430C-815E-3DFDE3F74041</gtr:id><gtr:title>Advantages of Double Diffusion Encoding over Single Diffusion Encoding sequences for biophysical models</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30c26a2170673a14e6c93c7f3bc69dd6"><gtr:id>30c26a2170673a14e6c93c7f3bc69dd6</gtr:id><gtr:otherNames>Coelho S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c78a220d2ff5.13955026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7E7F3DE-674C-4F5C-8D7F-621CAC1B3DE9</gtr:id><gtr:title>Generative statistical models of white matter microstructure for MRI simulations in virtual tissue blocks</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2da67ebf6460fef095601562d6f7d3e8"><gtr:id>2da67ebf6460fef095601562d6f7d3e8</gtr:id><gtr:otherNames>Beltrachini, L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56dd823ad97260.66488603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16497501-D81F-4CBA-A0B6-15A1CF9A0F3A</gtr:id><gtr:title>Simultaneous magnetic resonance diffusion and pseudo-diffusion tensor imaging.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e9bde1f7acf03c027d9ebfcdd05c5e0"><gtr:id>5e9bde1f7acf03c027d9ebfcdd05c5e0</gtr:id><gtr:otherNames>Mozumder M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5aa23deeb11002.09790256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CEE662F-38FD-432D-A4A9-A905EE688841</gtr:id><gtr:title>Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c89f7633a08b1e04b9d31559338618eb"><gtr:id>c89f7633a08b1e04b9d31559338618eb</gtr:id><gtr:otherNames>Di Marco LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>585d6c5a631199.20683481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49B8F9BA-59FE-4C87-AD22-7931384DF9FC</gtr:id><gtr:title>Precision Imaging: more descriptive, predictive and integrative imaging.</gtr:title><gtr:parentPublicationTitle>Medical image analysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a8e73dae65dfa1d72fec62415814c9e"><gtr:id>1a8e73dae65dfa1d72fec62415814c9e</gtr:id><gtr:otherNames>Frangi AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1361-8415</gtr:issn><gtr:outcomeId>585d6b9fa87cb6.16610042</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/M006328/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>A759BB04-AFFE-4780-BD31-9A2707BC44BA</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical Imaging</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>